NZ717883A - Monoclonal antibodies against her2 - Google Patents
Monoclonal antibodies against her2Info
- Publication number
- NZ717883A NZ717883A NZ717883A NZ71788311A NZ717883A NZ 717883 A NZ717883 A NZ 717883A NZ 717883 A NZ717883 A NZ 717883A NZ 71788311 A NZ71788311 A NZ 71788311A NZ 717883 A NZ717883 A NZ 717883A
- Authority
- NZ
- New Zealand
- Prior art keywords
- monoclonal antibodies
- antibodies against
- against her2
- disclosed
- her2
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Disclosed is a monoclonal antibody which binds human epidermal growth factor receptor 2 (HER2) comprising the CDRs of sequences as disclosed in the specification. Also disclose is the use of such antibodies for treating cancer.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34918010P | 2010-05-27 | 2010-05-27 | |
DKPA201000467 | 2010-05-27 | ||
PCT/EP2011/056388 WO2011131746A2 (en) | 2010-04-20 | 2011-04-20 | Heterodimeric antibody fc-containing proteins and methods for production thereof |
DKPA201100312 | 2011-04-20 | ||
NZ62984911 | 2011-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ717883A true NZ717883A (en) | 2018-12-21 |
Family
ID=66477015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ717883A NZ717883A (en) | 2010-05-27 | 2011-05-27 | Monoclonal antibodies against her2 |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ717883A (en) |
-
2011
- 2011-05-27 NZ NZ717883A patent/NZ717883A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ604007A (en) | Monoclonal antibodies against her2 epitope | |
NZ604003A (en) | Monoclonal antibodies against her2 | |
HK1253579A1 (en) | Monoclonal anti-gt468 antibodies for treatment of cancer | |
IL238668A0 (en) | Monoclonal antibodies against claudin-18 for treatment of cancer | |
MX2018010331A (en) | Vegf/dll4 binding agents and uses thereof. | |
WO2012143524A3 (en) | Bispecific antibodies against her2 and cd3 | |
NZ601588A (en) | Methods for treating breast cancer | |
NZ611785A (en) | Anti-notch1 antibodies | |
NZ626610A (en) | Antibodies that bind csf1r | |
SG194701A1 (en) | Anti-cd40 antibodies and methods of use | |
HRP20180485T1 (en) | Monoclonal antibodies for treatment of cancer | |
EP2579895A4 (en) | Anti-vegf antibodies and uses thereof | |
MX347320B (en) | Agr2 blocking antibody and use thereof. | |
MX2015002465A (en) | Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (igf-1). | |
NZ717883A (en) | Monoclonal antibodies against her2 | |
NZ757754A (en) | Antibodies that bind csf1r | |
NZ737925A (en) | Monoclonal antibodies against c-met |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 27 MAY 2021 BY CPA GLOBAL Effective date: 20190418 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 MAY 2022 BY CPA GLOBAL Effective date: 20210415 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 MAY 2023 BY CPA GLOBAL Effective date: 20220415 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 MAY 2024 BY CPA GLOBAL Effective date: 20230413 |